DFO
DBVT

Duquesne Family Office’s DBV Technologies DBVT Stock Holding History

Duquesne Family Office’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.01M Buy
+383,363
New +$8.01M 0.24% 61

Other funds holding DBVT

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Duquesne Family Office's DBVT Position: Q1 2026 in Review

Duquesne Family Office opened a new position in DBV Technologies (DBVT) in Q1 2026: 383,363 shares worth $8.01M. The stake represents 0.24% of the portfolio and ranks #61 among its holdings.

71 funds tracked by Wall St. Rank hold DBVT as of Q1 2026.

  • Duquesne Family Office held 383,363 shares of DBV Technologies worth $8.01M as of Q1 2026.
  • DBV Technologies was a new Duquesne Family Office position in Q1 2026.
  • DBV Technologies made up 0.24% of Duquesne Family Office's portfolio in Q1 2026, its #61 holding.
  • 71 funds tracked by Wall St. Rank held DBV Technologies as of Q1 2026.

Based on Duquesne Family Office's 13F filing for Q1 2026, filed 15 May 2026.